Toronto, Ontario– December 4, 2020– Embark Delta Inc., an entirely owned subsidiary of Embark Health Inc. (” Embark” or the “Business”) is happy to reveal that it has actually been approved a change to its licence for the sale of marijuana extracts, marijuana topicals and edible marijuana items from their center in Delta, British Columbia.
The modification to the Health Canada licence enables the Business to more broaden its existing and future item offerings to the medical and leisure customer markets with focuses, extracts and nanoemulsified topical and edible items. In addition, Embark can now provide white-labelling turn-key production services to its business accounts. Embark is presently producing Bubble Hash, Dry Sift, Standard Pushed Hash and Rosin at their Delta center.
” Getting our sales licence to enable the sale of extracts and focuses in combination with EmbarkNano topicals, edibles and drinks is another essential turning point in Embark’s course to development and success”, stated Dr. Luc C. Duchesne, Embark’s CEO. “The Embark portfolio of items addresses the developing requirements these days’s customer”.
Embark will bring items to market under the Embark Brands portfolio in order to satisfy the differing requirements of consumers; the very first of which is releasing in the coming weeks. “Even more, the EmbarkNano group has actually been establishing formulas to deal with the Health & & Health and Charm sectors of the marketplace”, stated Stephanie Fry, Embark’s Chief Commercial Officer. “We anticipate these item launches in Q1 2021 and think our items will set the requirement in the market.”
The group at Embark want to thank all individuals at Health Canada who have actually striven to keep connection regardless of the difficulties of working under the pressures of COVID-19.